Journal · Metabolic
Your Fat Is Moving. Is Anything Equipped to Finish the Job?
The short answer
The conversation about GLP-1 medications is almost entirely about appetite. Eat less, lose weight, done. That skips a step. Fat leaving a fat cell is not the same as fat leaving your body, and the pathway between those two things runs on nutrients most people have never thought about.
Questions this article answers
Everyone talks about the front half
Ask anyone what semaglutide or tirzepatide does and you will hear about appetite. It is the effect people feel, it is what the advertising shows, and it is real: these compounds act on appetite centres in the brain, and food simply matters less.
That is the front half of the process. A calorie deficit means the body goes looking for stored energy, and triglycerides come out of fat cells as free fatty acids into the bloodstream. This is where the public conversation stops.
But free fatty acids in your blood are not weight lost. They are fat in transit. What happens to them next is a separate piece of machinery with its own requirements, and it is the half nobody talks about.
Fat in transit has two gates to get through
Mobilised fatty acids take one of two routes. Some are taken up by muscle and other tissues and burned directly. The rest travel to the liver, which either oxidises them or packages them back into triglycerides for export, wrapped in a particle called VLDL.
That gives you two sequential gates between stored fat and used fat:
- Gate one, in the liver. Can the liver package fat and move it back out into circulation?
- Gate two, in the mitochondria. Can the cell get fatty acids inside the furnace where they are actually burned?
Neither gate opens on willpower. Both are built from specific molecules, and both run at the speed those molecules allow. When fat mobilisation increases sharply, the volume of work arriving at those gates increases with it.
Gate one: what the liver needs to export fat
The liver cannot assemble a VLDL particle without phosphatidylcholine. Phosphatidylcholine is built either directly from choline, or through the methionine cycle, which supplies the methyl groups to make it.
That is the whole basis of the lipotropic category, and it is why the four ingredients in a Lipo-B injection are the four they are. Metabolic Precision profiles the formulation at pp. 151–153:
- Choline is the direct precursor to phosphatidylcholine, the molecule the liver uses to build and ship out VLDL.
- Methionine is an essential amino acid that donates methyl groups through the methionine cycle, which is the other route to phosphatidylcholine.
- Inositol is a structural component of phosphatidylinositol lipids, which take part in lipid transport, and it acts as a second messenger in insulin signalling.
- Vitamin B12 keeps the methylation cycle turning, regenerating methionine from homocysteine so the methyl supply does not stall.
Four nutrients, one job between them: keeping the liver’s fat-handling pathway supplied. These are vitamins and amino acids, not drugs. They do what they do because of where they sit in the pathway, and a body short of any of them is running that pathway on less than it was designed for.
Which is the point of this article. If fat mobilisation has gone up sharply and these inputs were already marginal, the gate does not widen to match.
Gate two: what the mitochondria need to burn it
Getting fat out of the liver is one thing. Burning it is another, and it has its own gate.
Long-chain fatty acids, which make up most of what is stored in body fat, cannot cross into the mitochondria unaided. They have to be attached to carnitine by an enzyme at the outer membrane, carried across by a transporter, and released on the inside before beta-oxidation can begin. That is the step where fatty acids stop being cargo and start being fuel.
Metabolic Precision (pp. 148–151) is direct about what this means: without adequate carnitine, fat oxidation is limited regardless of how well everything downstream is working. The book also notes that reduced carnitine availability turns up in insulin-resistant states, in metabolic syndrome, and in older adults whose own synthesis has slowed, which describes a large share of the people starting a metabolic protocol in the first place.
This is where the two common formulations part ways. Lipo-B covers gate one. Carnitine is not in it. Metabolic Precision (pp. 153–155) covers Lipo-C, which is the same four nutrients plus L-carnitine, and therefore addresses both gates rather than one. If the question is specifically about oxidation rather than hepatic export, that difference is the whole answer.
Where the growth hormone axis comes into it
There is one more input to hepatic fat handling that has nothing to do with nutrients, and it is worth knowing about because it sits in the same part of the system.
Tesamorelin is a GHRH analog: it prompts the pituitary to release growth hormone, and the growth hormone axis influences how the liver and adipose tissue handle fat. It is an approved medicine for reducing excess abdominal fat in people with HIV-associated lipodystrophy, which is the population it was developed and licensed for.
We cover what it is, how it works and exactly what it is and is not licensed for on its compound profile, which is the right place for that detail. The reason it belongs in this article is simply that hepatic fat handling has more than one input: the nutrients that build the export machinery, and the hormonal signals that set how hard it runs.
Handling, sourcing and basic caution
Anything injectable deserves the same baseline care, and this category is no exception.
- Sterile technique. Clean hands, clean surface, a fresh needle every time, and proper sharps disposal. Infection risk at an injection site comes from handling far more often than from the contents.
- Storage. Follow the storage conditions the preparing pharmacy specifies, and do not use anything that has changed in colour or clarity.
- Source. A compounded preparation from a licensed pharmacy, on a prescription, is a different proposition from something bought online. With the second you are trusting a stranger about what is in the vial.
- Your own situation. Liver conditions, kidney conditions, methylation disorders and pregnancy all change the picture. So does everything else you are already taking. These are conversations for a clinician who knows your history.
Metabolic Precision (p. 153) also notes the practical points reported with lipotropic injections: mild discomfort at the site, and transient flushing. Nothing exotic, but worth knowing before the first one rather than after.
The question worth asking
When fat loss stalls or someone feels flat and heavy partway through a protocol, the usual question is what else can I take? It is the question the whole supplement market is built to answer.
The more useful question is which step is actually limiting. That has a different shape, because it can be looked into rather than guessed at. Is the diet still supplying choline and carnitine, or did the foods that carry them, eggs, liver, red meat, dairy, quietly disappear when intake dropped? What do the liver markers look like? What does B12 status look like? Those are all measurable, which turns an assumption into a number.
The second half of fat metabolism deserves as much attention as the first, and the machinery doing that work has requirements worth knowing about: what supplies the liver’s export pathway, what carries fatty acids into the furnace, and which of those a given formulation covers.
Questions people ask
What is in a Lipo-B injection?
Four things: methionine, inositol, choline and vitamin B12. Metabolic Precision (pp. 151–153) describes the formulation as targeting hepatic fat handling and methylation chemistry. It is a compounded nutrient preparation rather than a peptide or an approved medicine.
What is the difference between Lipo-B and Lipo-C?
Lipo-C is the same four nutrients plus L-carnitine. Lipo-B supports the liver’s ability to package and export fat; carnitine is what allows fatty acids to enter the mitochondria to be burned. Metabolic Precision (pp. 153–155) treats Lipo-C as the more complete formulation where oxidation is the step in question.
Why is choline involved in fat metabolism?
Because the liver builds VLDL particles, the vehicles that carry fat back out into circulation, using phosphatidylcholine. Choline is its direct precursor, and the methionine cycle is the other route to making it.
What does carnitine actually do?
It carries long-chain fatty acids across the mitochondrial membrane. Those fatty acids cannot get in on their own, so carnitine is the step between a fatty acid being available and a fatty acid being burned.
Do these need to be injected?
Choline, methionine, inositol, carnitine and B12 all occur in food and are available orally. The injectable route exists to bypass digestion and absorption. Whether that matters for a given person comes down to their own absorption and status rather than to a general rule.
Is any of this a substitute for diet and training?
No. These nutrients supply a pathway; they do not replace the deficit, the protein intake or the training that drive body composition in the first place. A protocol that has quietly removed eggs, red meat and dairy has removed the dietary source of several of them, which is worth noticing before adding anything.
Where this comes from in our books
This article is the plain-language version. The book sections below go further, with full mechanism detail, evidence tiers and how each idea fits a complete protocol. Page numbers refer to the print editions.
Metabolic Precision
L-Carnitine profile, the mitochondrial transport step · pp. 148–151
Read next
Put the framework to work
The free Protocol Builder applies the same category-first logic as the books, built from the same compound database.
Open the Protocol BuilderSee the book seriesHow this article is maintained. We review our articles and update them as things change; the date at the top shows the last review.
Educational information only, not medical advice. Nothing in this article is a recommendation to use any compound or a dosing guide. Talk to a qualified clinician before starting, stopping or combining any compound.